EPFL researchers created an AI-driven microscopy system that predicts and analyzes misfolded protein aggregation in real time.
Key Details
- 1Developed a self-driving imaging system combining multiple microscopy methods and deep learning.
- 2System predicts and detects protein aggregation—a hallmark of neurodegenerative diseases—in living cells.
- 3Uses label-free microscopy to minimize sample alteration and maximize imaging efficiency.
- 4Upon aggregation detection, system triggers Brillouin microscope to analyze biomechanical properties of aggregates.
- 5Aggregation onset detection achieved 91% accuracy using a specialized deep learning algorithm.
- 6Published in Nature Communications, with potential impact on drug discovery and precision medicine.
Why It Matters
This work showcases how AI-driven, label-free imaging can reveal dynamic, disease-relevant cellular processes in unprecedented detail, opening new pathways for diagnostic research and drug development in neurodegenerative diseases.
Source
EurekAlert
Related News
•EurekAlert
AI Predicts Risks for Outpatient Stem Cell Therapy in Myeloma
Researchers use machine learning to predict adverse events during stem cell therapy for multiple myeloma, improving outpatient safety.
•EurekAlert
USC Unveils Joint Biomedical Engineering Department Bridging Medicine, Engineering, and Imaging
USC's medical and engineering schools launch a joint biomedical engineering department to accelerate interdisciplinary research and innovation, including imaging and AI.
•EurekAlert
AI-Enhanced CT Heart Fat Measurement Boosts Cardiovascular Risk Prediction
AI-derived measurement of heart fat from CT scans significantly improves long-term cardiovascular disease risk prediction.